TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,178,000 | -74.7% | 43,883 | -55.1% | 0.00% | -50.0% |
| Q4 2021 | $4,664,000 | +132.4% | 97,769 | +223.6% | 0.00% | +100.0% |
| Q3 2021 | $2,007,000 | +24.0% | 30,214 | +45.6% | 0.00% | 0.0% |
| Q2 2021 | $1,619,000 | +7.4% | 20,755 | +30.2% | 0.00% | 0.0% |
| Q1 2021 | $1,508,000 | -51.2% | 15,941 | -37.2% | 0.00% | -50.0% |
| Q4 2020 | $3,091,000 | +44.3% | 25,364 | +3.5% | 0.00% | 0.0% |
| Q3 2020 | $2,142,000 | +495.0% | 24,515 | +339.9% | 0.00% | – |
| Q2 2020 | $360,000 | -57.0% | 5,573 | -75.0% | 0.00% | -100.0% |
| Q3 2019 | $837,000 | – | 22,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |